Revolutionizing Spatial Biology: Akoya Biosciences Unveils Game-Changing 2.0 Platforms

Akoya Biosciences Unleashes Breakthrough 2.0 Platforms, Paving the Way for Unprecedented Advancements in Spatial Biology

MARLBOROUGH, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences Inc. (Nasdaq: AKYA), known as The Spatial Biology Company®, is setting a remarkable new standard in spatial biology with the launch of PhenoCycler®-Fusion 2.0 and PhenoImager® HT 2.0 platform upgrades. These cutting-edge enhancements are revolutionizing whole-slide, spatial biology workflows by delivering unparalleled scale and speed.

PhenoCycler-Fusion 2.0 now empowers researchers to process double the number of samples per week, making it the highest throughput spatial discovery platform available. Meanwhile, the PhenoImager HT 2.0 platform boasts a jaw-dropping 5x improvement in workflow efficiency, enabling real-time image analysis directly on the instrument. With this groundbreaking capability, Akoya is propelling its customers toward new scientific breakthroughs, the identification of vital clinical biomarkers, and the creation of innovative spatial signatures.

Akoya’s CEO, Brian McKelligon, expressed the company’s dedication to ongoing innovation and technical leadership in spatial biology. He cited Akoya’s consistent market performance and robust intellectual property portfolio as the foundation for future long-term growth. “We eagerly anticipate supporting and empowering our next 1000 customers and contributing to 1000 more publications,” McKelligon said.

The PhenoCycler-Fusion 2.0 and PhenoImager HT 2.0 enhancements, combined with Akoya’s cutting-edge PhenoCode™ Discovery and Signature Panels, as well as proprietary file compression and rapid image analysis, are simplifying and accelerating spatial biology workflows at every stage, from panel development and validation to data analysis. These 2.0 Platforms are already being actively installed as field upgrades on existing systems, delivering immediate benefits in throughput expansion and significant reductions in the time required from sample to results.

Dr. John Hickey, Postdoctoral Fellow in the Department of Microbiology and Immunology at Stanford University School of Medicine, shared his excitement about the PhenoCycler-Fusion 2.0 upgrade: “Since upgrading, our throughput has doubled. The multi-slide functionality and other time-saving improvements have resulted in tremendous benefits. The capability to acquire whole-slide, processed, multiplexed imaging data at this pace is truly phenomenal, enabling the acquisition of single-cell data across millions of cells spatially, which is crucial for robust spatial studies.”

According to Dr. Linh Hoang, CEO of digital histopathology service provider HistoWiz, the PhenoImager HT 2.0 upgrade is significantly boosting workflow efficiency and ensuring the development and execution of complex high-plex multiplex projects are expedited while maintaining high-quality standards. The upgrade eliminates signal crosstalk, facilitating reproducible and reliable high-plex imaging.

With these extraordinary advancements, Akoya is spearheading a new era of spatial biology, where researchers can unlock unprecedented insights and accelerate scientific progress.

About Akoya Biosciences

Akoya Biosciences, known as The Spatial Biology Company®, is on a groundbreaking mission to revolutionize the world of biology and human health by harnessing the incredible power of spatial phenotyping. Their innovative single-cell imaging solutions provide researchers with the ability to not only phenotype cells but also understand their spatial context, illuminating how they organize and interact. This profound insight into the intricacies of disease progression and therapy response is poised to drive scientific discovery to new heights.

Akoya’s comprehensive suite of spatial phenotyping solutions caters to the diverse needs of researchers across all stages of scientific exploration, from discovery and translational research to clinical applications. Their offerings include PhenoCode™ Panels, PhenoCycler®, PhenoImager® Fusion, and PhenoImager HT Instruments, all designed to empower researchers to unlock the secrets of biology in ways previously unimaginable.

Leave a Comment